Does restaging transurethral resection of bladder tumor influence outcomes in patients treated with BCG immunotherapy? 491 cases in 20 years’ experience
Saved in:
| Main Authors: | Wojciech Krajewski, Romuald Zdrojowy, Katarzyna Kościelska-Kasprzak, Janusz Dembowski, Michał Wróbel, Mateusz Łuczak, Anna Kołodziej |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Medycyna Praktyczna
2018-12-01
|
| Series: | Videosurgery and Other Miniinvasive Techniques |
| Subjects: | |
| Online Access: | https://www.termedia.pl/Does-restaging-transurethral-resection-of-bladder-tumor-influence-outcomes-in-patients-treated-with-BCG-immunotherapy-491-cases-in-20-years-experience,42,34273,1,1.html |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Technical developments in transurethral resection of bladder tumours
by: Agata Pastuszak, et al.
Published: (2019-12-01) -
LEGAL BASIC OF BCG-THERAPY FOR BLADDER CANCER IN MUNICIPAL POLYCLINICS
by: M. M. Zorina, et al.
Published: (2016-10-01) -
Bladder Preservation With Transurethral Tumor Resection and Intravesical BCG Instillation in Superficial Muscle-Invasive Bladder Cancer: A 10-Year Follow-up
by: Dong Gyun Kim, et al.
Published: (2023-03-01) -
Systematic Review and Meta-Analysis of Response Rates in BCG-unresponsive Non–Muscle-Invasive Bladder Cancer: a Consensus Statement From the International Bladder Cancer Group
by: Kyle M. Rose, et al.
Published: (2022-09-01) -
Rationale of restaging transurethral resection of bladder tumor in patients with nonmuscle invasive bladder cancer in the current era
by: Amit Sharma, et al.
Published: (2024-10-01)